60
Participants
Start Date
August 4, 2021
Primary Completion Date
February 4, 2022
Study Completion Date
February 4, 2022
Buccal Swabs, Blood Draws and Skin Punch Biopsy
Buccal Swabs - FXN and specific RNA markers; Blood Draws - Lipid panel, Protein Marker Analysis and Gene RNA Analysis; Skin Punch Biopsy - Protein Markers
Clinilabs Drug Development Corporation, Eatontown
Lead Sponsor
Collaborators (1)
Clinilabs, Inc.
OTHER
Larimar Therapeutics, Inc.
INDUSTRY